NextCure to terminate Chief Medical Officer Udayan Guha effective October 31, 2026

NXTC•2026-10-30

NextCure plans to terminate Chief Medical Officer Udayan Guha effective October 31, 2026, in contemplation of its pending merger with Avere Therapeutics.

1. Termination filing

NextCure said in an SEC filing that it will terminate Chief Medical Officer Udayan Guha effective October 31, 2026. The filing said the termination is in contemplation of the pending merger with Avere Therapeutics.

Sources

NextCure terminates Chief Medical Officer Udayan Guha effective Oct. 31

Sec

NextCure to terminate Chief Medical Officer Udayan Guha effective October 31, 2026

1. Termination filing

Related News

Hongli Group in talks to acquire 20% stake in Xell Energy

Raymond James raises Republic Services target price to $252 from $235

US Q3 employment costs data

Sources

NextCure terminates Chief Medical Officer Udayan Guha effective Oct. 31

Gladstone Land Corporation publishes update to financial calendar

MDA Space secures contract worth over $100 million to supply Thales Alenia Space with satellite antennas